Further investigation is necessary to establish whether CST2 can serve as a novel target for cancer diagnosis, treatment, and prognosis across different cancer types, as well as its potential value in predicting the efficacy of anti-tumor immune responses. This evidence concerns the gene CST2 and neoplasm.